Remove Competition Remove Patents Remove San Diego Remove Seed Funding
article thumbnail

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). billion acquisition of San Diego’s Auspex Pharmaceuticals last year.

article thumbnail

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

So far at the company I have raised seed funds of $500,000 of which $470,000 is still in the bank so I’m in pretty good shape. Distributed version control model – first in the industry like ours and we are filing patents. Page 3: Competition. Prepare to give your pitch in 30 including Q&A. Page 5: Financials.